Protein engineering responses to the COVID-19 pandemic

Area of Science:

• Vaccinology and Virology
• Structural Biology
• Immunology

Background:

• High-resolution structures of viral glycoproteins are crucial for designing effective vaccines.
• Previous vaccine development for COVID-19 has leveraged antigen design principles.
• Nanoparticle display systems offer a platform for multivalent antigen presentation.

Purpose of the Study:

• To discuss structure-based antigen design strategies for COVID-19 vaccine development.
• To explore the use of computationally optimized nanoparticles for antigen display.
• To highlight potential next-generation vaccine candidates against SARS-CoV-2 variants and emerging coronaviruses.

Main Methods:

• Utilizing high-resolution viral glycoprotein structures for antigen design.
• Employing conjugation systems to link antigens to nanoparticles.
• Computationally optimizing nanoparticle platforms for multivalent antigen display.
• Assessing humoral immunity, neutralization potency, and breadth in response to vaccine candidates.

Main Results:

• Structure-guided antigen design has yielded diverse COVID-19 vaccine candidates.
• Nanoparticle display of multivalent antigens with beneficial substitutions induced robust immunity.
• Enhanced neutralization potency and breadth were observed with these vaccine strategies.

Conclusions:

• Structure-based antigen design combined with nanoparticle display is a powerful approach for developing effective vaccines.
• This strategy holds promise for creating next-generation vaccines against current and future coronavirus threats.
• Further research can optimize these methods for broader coronavirus protection.